pone.0227440.g004.tif (881.66 kB)
Recurrence rates according to FGFR2 grade, modified UICC, VEGF, TRAIL receptor 1, TRAIL receptor 2, and E-S grade.
figure
posted on 2020-01-15, 21:07 authored by Baek Gyu Jun, Woong Cheul Lee, Jae Young Jang, Soung Won Jeong, Young Chang, Sae Hwan Lee, Young don Kim, Sang Gyune Kim, Gab Jin Cheon, Young Seok Kim, Hong Soo Kim, So Young JinKaplan-Meier estimates of (A) FGFR2, (B) modified UICC, (C) VEGF, (D) TARIL-R1, (E) TRAIL-R2, and (F) E-S grade designated as low (or early) or high (or advanced). (A) Increased FGFR2 expression was associated with recurrence. There were no significant differences in recurrence rates related to (B) modified UICC, (C) VEGF, and (E) TRAIL-R2. There was tendency toward high recurrence rate related to (D) low TRAIL-R1, difference not statistically significant. P-values were obtained from the log-rank test.
History
Usage metrics
Categories
Keywords
International Cancer ControlHCC recurrencefibroblast growth factor receptor 2 expressionfibroblast growth factor receptor 2E-S gradehepatocellular carcinoma recurrenceHCC patientsConclusions High FGFR 2 expressionliver resection Background Hepatocellular carcinomaUICC5- year recurrence ratesFGFR 2 expressionliver resectionSDtumor-necrosis-factor-related apoptosis-inducing ligand receptors 1
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC